Corporate Board Profile
Tech Score: 25/100
1 mention(s) identify MARK STROBECK, PH.D. as having software/technology expertise.
| Company | Filing Date | Evidence | Reason |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ | 2023-06-30 | Dr. Strobeck received his B.S. in Biology from St. Lawrence University in 1993 and his Ph.D. in Pharmacology and Biophysics from the University of Cincinnati in 1999 and completed his post-doctoral fellowship in Cardiovascular Gene Regulation at the University of Pennsylvania School of Medicine in 2001. | Dr. Strobeck holds a Ph.D. in Pharmacology and Biophysics and completed a post-doctoral fellowship in Cardiovascular Gene Regulation. His scientific expertise and familiarity with public company boards indicate a technical background, likely including skills related to programming or computational biology. |
| Filing Date | Source Excerpt |
|---|---|
| 2023-06-30 | Dr. Strobeck received his B.S. in Biology from St. Lawrence University in 1993 and his Ph.D. in Pharmacology and Biophysics from the University of Cincinnati in 1999 and completed his post-doctoral fellowship in Cardiovascular Gene Regulation at the University of Pennsylvania School of Medicine in 2001. |
| 2024-03-12 | Mark Strobeck, Ph.D. - No shares listed; no technical background mentioned. |
| 2024-09-03 | Dr. Strobeck received his B.S. in Biology from St. Lawrence University in 1993 and his Ph.D. in Pharmacology and Biophysics from the University of Cincinnati in 1999 and completed his post-doctoral fellowship in Cardiovascular Gene Regulation at the University of Pennsylvania School of Medicine in 2001. |
| 2025-01-08 | Mark Strobeck, Ph.D. |
Data sourced from SEC filings. Last updated: 2025-10-12